Have you been diagnosed with primary hypothyroidism for at least 12 months-
Have you been on continuous thyroid replacement therapy with an FDA approved dose of Synthroid or Levothyroxine for at least 12 months, and at a stable dose for at least 3 month and a TSH in the last year you could qualify this study.
New thyroid study now enrolling, for more information call:
Debbie Clark at 901-448-2676, or email her at dmclark@uthsc.edu